Envveno MedicalNVNO
13F holders, Q1 2026 (March 31)17holders
$10.13avg. 13F price*
At the end of Q1 2026, 17 institutions reported holding Envveno Medical Corp. (NVNO) in their 13F filings. The largest holders were Kingdon Capital Management, L.L.C. ($366K), CM Management, LLC ($362K) and Geode Capital Management, LLC ($106K).
- Company
- Envveno Medical Corp.
- CUSIP
- 29415J205
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $6K |
| Exits | 0 | $0 |
Ownership 17 holders
| Kingdon Capital Management, L.L.C. | 0.06% | Reduce -0.1% | 36,166 | $366K |
| CM Management, LLC | 0.30% | Reduce -0.1% | 35,714 | $362K |
| Geode Capital Management, LLC | 0.00% | Add +81.7% | 10,455 | $106K |
| Vanguard Capital Management LLC | 0.00% | — | 6,287 | $64K |
| JPMorgan Chase & Co. | 0.00% | No change | 5,209 | $53K |
| Vanguard Fiduciary Trust Co. | 0.00% | — | 2,184 | $22K |
| BlackRock, Inc. | 0.00% | Add +6.4% | 1,840 | $19K |
| Westside Investment Management, Inc. | 0.00% | Reduce -40.0% | 1,589 | $16K |
| Tower Research Capital LLC (TRC) | 0.00% | New | 542 | $5K |
| UBS Group AG | 0.00% | Reduce -73.5% | 243 | $2K |
| Wells Fargo & Company | 0.00% | Add +99.3% | 114 | $1K |
| Vanguard Global Advisers, LLC | 0.00% | — | 77 | $780 |
| Morgan Stanley | 0.00% | Reduce -7.5% | 76 | $770 |
| Osaic Holdings, Inc. | 0.00% | Reduce -2.1% | 7 | $70 |
| Group One Trading LLC | 0.00% | Reduce -96.0% | 2 | $20 |
| Northwestern Mutual Wealth Management Co. | 0.00% | New | 2 | $20 |
| Citigroup Inc. | 0.00% | New | 1 | $10 |
"% of holder's portfolio" is NVNO's weight in each manager's 13F, not the share of Envveno Medical Corp. the manager owns.